1 June 2012
The antioxidant supplement beta-carotene has been deemed safe when used in prostate cancer treatments, following a study on the procedure.
Danielle Margalit, a radiation oncologist at Boston's Dana-Farber Cancer Institute, led the research, which looked into a controversial radiation treatment technique for fighting the life-threatening disease.
The study group analysed 383 prostate cancer patients, who were subjected to treatments either involving beta-carotene or placebo therapy.
According to the research results, which have been published in the International Journal of Radiation Oncology, Biology, Physics, there were no major differences between those who were subjected to the antioxidant beta-carotene and those who opted for the placebo treatment.
Ms Margalit noted: "This study shows that antioxidant supplementation with beta-carotene during radiation therapy does not appear to detract from the benefit of radiation therapy."
Prostate cancer is still a major health issue across Britain, with Cancer Research UK stating that 40,841 new cases of the disease were diagnosed across the country in 2009 alone.
Posted by Edward Bartel
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.